Wednesday, June 16, 2021

Gene Panel Market Opportunities, Top Manufactures, Industry Growth, Share, Size, Regional Analysis and Global Forecast to 2028

Rising prevalence of cancer across the globe and increasing usage of gene panel in targeted therapies for cancer are key key factors boosting market revenue growth

Market size: USD 1.8 billion in 2020, Market Growth: CAGR of 19.6%, Market Trends: Technological advancements in diagnostics sector   

The Global Gene Panel Market size is expected to reach USD 7.24 billion in 2028 and register a CAGR of 19.6% over the forecast period, according to the latest report by Reports and Data. Key factors such as rising adoption of genetic testing and increasing disorders due to genetic mutation are augmenting demand for gene panels and fueling global market revenue growth. 


Gene panel tests help in analyzing multiple genes for cancer-related alterations at the same time and comprise two specific genes – BRAC1 and BRAC2 – that are in charge of generating proteins that suppress tumors and prevent growth of tumor cells and also help in repairing damaged DNA. Rising prevalence of genetic diseases caused by genetic mutations, rapidly increasing number of cancer cases, advancements in NGS technology, and growing adoption of gene panels – particularly in developed economies – are some other factors fueling global market growth. In addition, major players are investing in research and development activities with rising focus on developing more enhanced products. In addition, government funding and support for population sequencing is another key factor expected to boost global market growth going ahead. 

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/4087

However, stringent regulations imposed on pharmaceutical companies, low awareness regarding advantages of using gene panels in some developing countries, and rising concerns regarding safety of genetic data are some factors expected to limit growth of the gene panel market over the forecast period. 

Some key highlights from the report:

  • Among the product & services segments, the test kits segment is projected to account for significantly large revenue share during the forecast period due to increasing demand for gene panel kits, especially in research and diagnostics centers, owing to rising prevalence of various infectious diseases and genetic disorders in countries around the globe. 
  • Among the technique segments, the hybridization-based approach segment revenue is expected to expand at a fast CAGR between 2021 and 2028 due to growing adoption of this technique due to its use for genotyping and sequencing rare variants. 
  • Among the application segments, the cancer risk assessment segment is expected to account for substantial revenue growth throughout the forecast period owing to increasing prevalence of cancer and growing demand for gene panels in genomic research and diagnostics sectors.  
  • Asia Pacific market is expected to register robust double-digit revenue CAGR of 18.7% over the forecast period owing to factors such as large patient pool, rapidly increasing number of cancer cases, and increasing healthcare expenditure in countries in the region. 
  • Europe is projected to account for robust revenue share during the forecast owing to increasing prevalence of cancer, launch of enhanced gene panels, and high funding for research and development activities in countries in the region. 
  • Major players operating in the global gene panel market are Agilent Technologies Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen (Germany), Illumina Inc. (US), BGI Genomics (China), Integrated DNA Technologies, Inc. (US), GENEWIZ (US), Novogene Corporation (US), Personalis, Inc. (US), GATC Biotech AG (Germany), ArcherDX, Inc. (US), GeneDx (Switzerland), and CENTOGENE AG (Germany).

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4087

For this study, Reports and Data has segmented the global gene panel market based on product & services, technique, design, application, end use, and region:

Based On Product & Services (Revenue, USD Billion, 2018 - 2028)

  • Test Kits
  • Testing Services

Based On Technique (Revenue, USD Billion, 2018 - 2028)

  • Amplicon-based Approach
  • Hybridization-based Approach

Based On Application (Revenue, USD Billion, 2018 - 2028)

  • Cancer Risk Assessment
    • Syndrome-specific
    • High-penetrance
    • High and Moderate-penetrance
    • Comprehensive Cancer Risk
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Other Applications

Based On Design (Revenue, USD Billion, 2018 - 2028)

  • Predesigned Gene Panel
  • Customized Gene Panel

Based On End Use (Revenue, USD Billion, 2018 - 2028)

  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4087

Based On Region: (Revenue, USD Billion, 2018 - 2028)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA

Key Questions Addressed in the Report:

  • What are the key outcomes of SWOT analysis and Porter’s Five Forces Analysis?
  • Which are the key companies operating in the Gene Panel market?
  • What are the key revenue growth driving and restraining factors of the Gene Panel industry?
  • What business strategies are the top companies rapidly adopting to gain market size?
  • Which region is expected to account for largest revenue share in the global market?

The Global Gene Panel Market report covers the assessment of the key players and their market scope through advanced analytical tools such as SWOT analysis, Porter’s Five Forces analysis, feasibility study, and investment return analysis. The statistical analysis provides accurate assessment of the growth of the major manufacturers/companies operating in the industry. The report covers analysis of the factors that directly influence the growth of the market such as marketing strategies, development platforms, product portfolio, and others.

To know more about the report @ https://www.reportsanddata.com/report-detail/gene-panel-market

 Table of Content:

  1. Introduction
    2. Key Takeaways
    3. Gene Panel Market Landscape
        3.1. Market Overview
        3.2. Market Segmentation
               3.2.1. Gene Panel Market - By Product & Services
               3.2.2. Gene Panel Market - By Technique
               3.2.3. Gene Panel Market - By Application
               3.2.4. Gene Panel Market - By Design
               3.2.5. Gene Panel Market - By Region
                        3.2.5.1. By Country
        3.3. Pest Analysis
               3.3.1. North America - PEST Analysis
               3.3.2. Europe - PEST Analysis
               3.3.3. Asia Pacific - PEST Analysis
               3.3.4. Latin America- PEST Analysis
               3.3.5. Middle East and Africa - PEST Analysis
    4. Gene Panel Market - Key Industry Dynamics
        4.1. Key Market Drivers
        4.2. Key Market Restraints
        4.3. Key Market Opportunities
        4.4. Future Trends
        4.5. Impact Analysis
    5. Gene Panel Market - Global Analysis
    5.1. Global Gene Panel Market Overview
    5.2. Global Gene Panel Market Revenue Forecasts And Analysis 
    5.3. Market Positioning/Market Share
    5.4. Performance Of Key Players
    5.5. Clinical Trials
    5.6. Expert Opinions
  2. Gene Panel Market Revenue And Forecasts 2018 To 2028- By Product & Services

Continued….

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.

Lateral Flow Assays Market Players Update, Emerging Technologies, Development Status, Competitive Landscape and Historical Analysis Forecast to 2028

Rising prevalence of infectious diseases globally is driving revenue growth of the market 

Market Size – USD 8.2 Billion in 2020, Market Growth – at a CAGR of 4.6%, Market Trends –Growing demand for point-of-care testing products

The Global Lateral Flow Assays Market size is expected to reach USD 11.66 billion by 2028 at a CAGR of 4.6%, according to the latest report by Reports and Data. Rising consumption rate for home-based lateral flow testing solutions and products, and growing requirement of better point-of-care testing products are a few major factors driving the revenue growth of the lateral flow assays market.  



Lateral flow assay involves antibodies and probe DNA biochemical interaction. This diagnostic method ensures simplified test with low costs and no requirement of any interference while the test is being conducted. Moreover, the test can also be easily conducted by non-trained individuals due to its highly user-friendly form of testing.

Increasing geriatric population leads to rising prevalence of different types of infectious diseases across the globe, which is one of the most crucial factors expected to propel the revenue growth of the lateral flow assays market during the forecasted period.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/4086

However, lack of preference from consumers to shift from conventional diagnostic testing methods and adopting advanced methods is one of the significant factors predicted to restrain the market revenue growth to a certain extent between 2021 & 2028.

Further key findings in the report

  • The clinical testing segment is expected to hold largest revenue share in the market during the forecast period due to its significance in disease detection along with a sharp rise in the incidence of different types of infectious diseases. 
  • The food safety & environment testing segment is predicted to register highest revenue share in the lateral flow assays market going ahead. Increasing revenue growth of this segment is attributed to growing demand for lateral flow assays as well as rapid alternatives to various traditional diagnostic methods, especially for detecting foodborne pathogens and contaminants.
  • The market in North America is expected to account for the largest revenue share in the global lateral flow assays market during the forecast period. Large revenue share of this regional market is resultant of presence of several hospitals and healthcare systems and the increasing geriatric population in the region.
  • Major companies operating in the market are F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), Rad Laboratories (U.S.), bioMérieux SA (France), Bio Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Quidel Corporation (U.S.), Hologic Inc. (U.S.), Merck KGaA (Germany), Abcam plc (UK).

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4086

For the purpose of this report, Reports and Data has segmented the global lateral flow assays market on the basis of product, application, technique, sample type, end user, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2028)

  • Kits & Reagents
  • Lateral Flow Readers
    • Digital/Handheld Readers
    • Benchtop Readers
    • Mobile/Smartphone Readers

Application Outlook (Revenue, USD Billion, 2018 - 2028)

  • Clinical Testing
    • Infectious Disease Testing
      • Mosquito-borne Diseases
      • Covid-19
      • Influenza
      • Sexually Transmitted Infections
        • HIV
        • HPV
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • Other Sexually Transmitted Infections
      • Hepatitis
      • Tuberculosis
      • Other Infectious Diseases
    • Cardiac Marker Testing
      • Troponin I and T Testing
      • CK-MB Testing
      • BNP or NT-proBNP Testing
      • Myoglobin Testing
      • D-Dimer Testing
      • Other Cardiac Markers
    • Pregnancy & Fertility Testing
      • Pregnancy Testing
      • Fertility Testing
    • Cholesterol Testing/Lipid Profiles
    • Drugs-of-Abuse Testing
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Technique Outlook (Revenue, USD Billion, 2018 - 2028)

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays 

Sample Type Outlook (Revenue, USD Billion, 2018 – 2028)

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Other Samples 

Download Summary @ https://www.reportsanddata.com/download-summary-form/4086

End User Outlook (Revenue, USD Billion, 2018 - 2028)

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Pharmaceutical & Biotechnology Companies
  • Other End Users 

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • MEA
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/lateral-flow-assays-market

 Report Highlights:

  1. The latest report on the global Lateral Flow Assays market offers an elaborate list of the company profiles of the top industry players.
  2. The report highlights the most significant aspects of the industry, such as manufacturing/production capacity, sales, future expansion strategies, and the financial positions of the manufacturers and top companies.
  3. The report emphasizes the key application areas of the leading market products & services.
  4. The report involves a SWOT analysis of the global Lateral Flow Assays market.
  5. The report provides vital information about the leading investors, stakeholders, policymakers, manufacturers, suppliers, and service providers involves in the Lateral Flow Assays industry.
  6. Furthermore, the latest study is a precise account of the market and offers actionable insights into the global market size and growth rate over the estimated period.

Table of Content:

Chapter 1 Introduction 

    1.1 Objectives Of The Study
    1.2 Market Definition
           1.2.1 Category-Wise Inclusions And Exclusions In The Lateral Flow Assays Market
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered For The Study
    1.4 Currency
           1.4.1 Exchange Rates Utilized For Conversion To Usd
    1.5 Limitations
    1.6 Stakeholders
    1.7 Summary Of Changes

Chapter 2 Research Methodology 

    2.1 Research Approach
           2.1.1 Research Design
           2.1.2 Secondary Data
                    2.1.2.1 Key Data From Secondary Sources
           2.1.3 Primary Data
                    2.1.3.1 Primary Sources
                    2.1.3.2 Key Data From Primary Sources
                    2.1.3.3 Breakdown Of Primaries
       Figure 1 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region
    2.2 Market Size Estimation
 Figure 2 Market Size Estimation: Revenue Share Analysis.
 Figure 3 Market Size Estimation: Revenue Share Analysis.
 Figure 4 Supply-Side Analysis: Lateral Flow Assays Market.
 Figure 5 Approach 3: Demand-Side Approach, Based On The Malaria Lateral Flow Testing Market Size.
 Figure 6 Cagr Projections: Supply-Side Analysis Of The Lateral Flow Assays Market.
 Figure 7 Cagr Projections From The Analysis Of Drivers, Restraints, Opportunities, And Challenges Of The Lateral Flow Assays Market (2020-2025)
    2.3 Market Breakdown & Data Triangulation
 Figure 8 Data Triangulation Methodology
    2.4 Market Share Estimation
    2.5 Assumptions For The Study
    2.6 Covid-19 Health Assessment
    2.7 Covid-19 Economic Assessment
    2.8 Assessment Of The Impact Of Covid-19 On The Economic Scenario
 Figure 9 Criteria Impacting The Global Economy
    2.9 Assessment Of The Impact Of Covid-19 On The Economic Scenario In The Lateral Flow Assays Market

Chapter 3 Executive Summary 

Continued….

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.

Sunday, June 13, 2021

Neglected Tropical Diseases (NTD) Diagnosis Market Share, Growth, Trend Analysis and Forecast 2028

 Growing adoption of Point-of-care testing services and introduction of home healthcare facilities are key factors fueling global market growth 

Market size: USD 6.01 Billion 2020, Market Growth: CAGR of 4.3%, Market Trends: Advancements in diagnostic technology 

The global Neglected Tropical Diseases (NTD) Diagnosis Market size is expected to reach USD 8.63 billion by 2028 and register a CAGR of 4.3%, according to the latest report by Reports and Data. Rising prevalence of various neglected tropical diseases around the globe and several government initiatives to raise awareness about these diseases are driving global market revenue growth. 



Neglected tropical diseases (NTD) are caused by bacteria, viruses, and parasites in low-income populations owing to poor health and hygiene, lack of proper sanitation, and clean water. Chikungunya, lymphatic Filariasis, taeniasis/cysticercosis, and dengue are common neglected tropical diseases. One of the primary factors fueling global market growth is increasing awareness about significance of early detection of NTD and growing efforts for improving healthcare facilitates across the globe. In addition, increasing investments for research and development of diagnostic tools and rising government programs to tackle neglected tropical diseases are further boosting global market. 

Get a sample of the report @ https://www.reportsanddata.com/discount-enquiry-form/4059

However, factors, such as high-priced diagnostic tools, unavailability of skilled professionals to operate advanced diagnostic systems, and imposition of unfavorable regulations, are expected to hamper growth of the global neglected tropical diseases diagnosis market over the forecast period.

Some key highlights in the report:

  • Based on the disease type, the lymphatic filariasis segment is expected to register fastest revenue CAGR over the forecast period owing to rising prevalence of lymphatic system disorders worldwide and growing adoption of rapid antigen tests. 
  • Among the diagnostic methods, the conventional methods segment is expected to account for significant revenue growth owing to high availability and usage of conventional methods such as serology tests, pathology culturing, and gram staining. Though the modern methods are more reliable.
  • The clinical laboratories segment accounted for largest revenue share in 2020 and is expected to continue its dominance over other end-use segments in the global neglected tropical diseases diagnosis market over the forecast timeline. High revenue share is attributable to increasing number of clinical laboratories, rising prevalence of neglected tropical diseases, and availability of advanced diagnostic kits across several countries. 
  • North America is expected to account for significant revenue share over the forecast period. Factors, such as rising prevalence of neglected tropical diseases, availability of rapid diagnostic services, and growing adoption of POC testing at home healthcare are key factors fueling market growth. 
  • The market in the Middle East and Africa is expected to account for high revenue growth throughout the forecast period owing to growing recurrence of NTDs and increasing adoption of modern diagnostic services. 
  • Key players operating in the global neglected tropical diseases diagnosis market include Thermo Fisher Scientific Inc, ZeptoMetrix Inc, InBios International Inc, Abbott, Genome Diagnostics Pvt. Ltd, Coris Bioconcept SPRL, Omega Diagnostics Group PLC, DiaSys Diagnostic Systems GmbH, and Oscar Medicare Pvt. Ltd.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4059

For this study, Reports and Data has segmented the global neglected tropical diseases diagnosis virus testing market based on disease diagnostic method, service type, end-use, and region:

Disease Outlook (Revenue, USD Million, 2018 - 2028)

  • Dengue
  • Chikungunya
  • Rabies
  • Leprosy
  • Buruli Ulcer
  • Yaws
  • Lymphatic Filariasis
  • Taeniasis/Cysticercosis
  • Foodborne Trematodiases
  • Echinococcosis
  • Chagas Disease (American Trypanosomiasis)
  • Dracunculiasis
  • African Trypanosomiasis
  • Soil-transmitted Helminth Infections
  • Onchocerciasis
  • Schistosomiasis
  • Scabies and Other Ectoparasites
  • Snakebite Envenoming
  • Leishmaniasis

Diagnostic Method Outlook (Revenue, USD Million, 2018 - 2028)

  • Conventional Method
  • Molecular/Modern Method

Service Type Outlook (Revenue, USD Million, 2018 - 2028)

  • Centralized Service
  • POC (Point-of-care) Service

End-use Outlook (Revenue, USD Million, 2018 - 2028)

  • Clinical Laboratories
  • Hospitals and Clinics
  • Home Healthcare
  • Others

To know more about the report @ https://www.reportsanddata.com/report-detail/neglected-tropical-diseases-diagnosis-market

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA

Key Features of the Neglected Tropical Diseases Diagnosis Report:

  • The report encompasses Neglected Tropical Diseases Diagnosis market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
  • Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
  • The report covers an extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Neglected Tropical Diseases Diagnosis industry
  • SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis
  • Sophisticated analysis of the market statistics and is represented in graphs, tables, facts, figures, diagrams, and charts to provide a better understanding

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4059

Thank you for reading our report. Customization is available on the report. To know more, please connect with us and our team will ensure the report is customized as per your requirements.

Malaria Diagnostics Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2028

 Growing need to eradicate malaria through diagnosis and treatment is expected to fuel market growth.

Market Size – USD 747 Million in 2020 Market Growth – 6% Market Trends – Increasing demand for timely malaria detection

The Global Malaria Diagnostics Market size is expected to reach USD 1.1 billion by 2028, registering a CAGR of 6% over the forecast period, according to the latest report by Reports and Data. Major factor driving market revenue growth is growing need to eradicate malaria through diagnosis and treatment. Malaria is one of the most prevalent life-threatening diseases, affecting tropical and subtropical regions as a result of shifting climates, low economic development, underdeveloped healthcare facilities, and a lack of advanced treatment options.

According to the World Health Organization (WHO), 229 million cases of malaria were recorded globally in 2019, with 94 % of those cases occurring in the Africa region.

Get a sample of the report @ https://www.reportsanddata.com/discount-enquiry-form/4058

Malaria claimed the lives of an around 409,000 people worldwide in 2019. The most vulnerable population to malaria is children under the age of five, who accounted for 67 % of all malaria deaths worldwide in 2019. On the other hand, 31 countries accounted for most of the global malaria deaths in the same year. Deaths in malaria deaths in Nigeria, the Democratic Republic of the Congo, Tanzania, Mozambique, Niger, and Burkina Faso accounted for roughly 51% of all malaria deaths worldwide.

WHO guidelines have recommended that all suspected malaria cases undergo a confirmatory test with microscopy or a Rapid Diagnostic Test (RDT) to confirm the diagnosis and WHO's "test, treat, and track" policy has supported this recommendation since 2012. Despite the fact that malaria continues to be a public health issue with over 300,000 children under the age of five dying each year, recent control efforts have significantly reduced the disease burden, especially in high-transmission areas of Africa. Introduction of RDT technology has prompted a shift in policy toward confirmatory testing, allowing malaria diagnosis in remote and resource-poor areas, which will propel revenue growth of the malaria diagnosis market.

In addition, growing demand for malaria diagnosis and treatment in Asia Pacific and Latin America will drive market growth. A recent UNITAID article estimates that over 400 million malaria rapid diagnostic test treatments will be needed over the next three years to eliminate global malaria prevalence.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4058

Because of its enormous impact on global health, scientific advancements in malaria diagnosis have been made. Alternative diagnostics methods with more efficient diagnostic solutions are becoming more common. The rising demand for effective malaria diagnosis will also help the market growth in the future.

Lack of awareness about availability of malaria diagnostics in developing countries may restrain evenue growth of the market to a certain extent going ahead. Furthermore, existing diagnostic tests are outdated, making the introduction of new technology-based diagnostic tests difficult.

Some Key Highlights in the Report:

  • The microscopy segment is expected to register largest market share due to the technique's intermittent use for disease diagnosis.
  • Rapid diagnostic tests accounted for considerable share in the malaria diagnostics market in 2020, owing to advantages associated with their use in diagnosis of malaria.
  • The clinics segment of the malaria diagnostics market accounted for largest market share among other end user segments in 2020.
  • The market revenue from Africa diagnostics market is expected to grow at a significant rate over the forecast period.
  • Asia Pacific region is expected to hold considerable revenue share due to the ongoing technological research and development activities in the field of malaria diagnostics.
  • Some of the prominent players in the malaria diagnostics market include Abbott, Access Bio, bioMérieux SA., Bio-Rad Laboratories, Inc., Danaher (Beckman Coulter), Novartis AG, Premier Medical Corporation, Siemens Healthineers and Thermo Fisher Scientific.

To know more about the report @ https://www.reportsanddata.com/report-detail/malaria-diagnostics-market

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global malaria diagnostics market on the basis of technology, end user and region:

Technology Outlook (Revenue, USD Million; 2018 – 2028)

  • Microscopy
  • Rapid Diagnostic Tests (RDTs)
  • Molecular Diagnostic Tests
    • Conventional PCR
    • Real-Time PCR (qPCR)

End-user Outlook (Revenue, USD Million; 2018 – 2028)

  • Hospital 
  • Clinics
  • Diagnostic Centres

Regional Outlook (Revenue, USD Million, 2018 – 2028)

  • Africa
    • Nigeria
    • Democratic Republic of Congo
    • Uganda
  • Southeast Asia
    • India
    • Myanmar
    • Indonesia
  • Eastern Mediterranean
    • Saudi Arabia
    • Pakistan
  • Western Pacific
    • China
    • Papua New Guinea
    • Cambodia
  • Americas
    • Venezuela
    • Brazil
    • Colombia
  • Europe
    • Turkey
    • France
    • K.
    • Germany

Key Features of the Malaria Diagnostics Report:

  • The report encompasses Malaria Diagnostics market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
  • Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
  • The report covers an extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Malaria Diagnostics industry
  • SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis
  • Sophisticated analysis of the market statistics and is represented in graphs, tables, facts, figures, diagrams, and charts to provide a better understanding

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4058

Thank you for reading our report. Customization of the report is available as per client’s needs. Please get in touch with us and our team will ensure you get the report tailored as per your requirements.

Table of Content:

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 R&D’s internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market formulation & data visualization
                   1.6 Data Validation & Publishing
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Related/ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Industry Value Chain Analysis
                       3.3.1 Raw Material Trends
                           3.3.1.1 Major Raw Materials Market Analysis
                           3.3.1.2 Procurement Best Practices
                       3.3.2 Manufacturing Trends
                           3.3.2.1 Technology Trends
                           3.3.2.2 Outsourcing & Contract Manufacturing Trends
                           3.3.2.3 Cost Structure Analysis
                       3.3.3 User perspective analysis
                           3.3.3.1 Consumer Behaviour Analysis
                           3.3.3.2 Market Influencer Analysis
                       3.3.4 Procedure cost analysis/breakdown
                       3.3.5 List of Key End-users, by region / by product / by country
                   3.4 Technology Overview
                       3.4.1 Technology Timeline
                   3.5 Regulatory Framework
                       3.5.1 Reimbursement framework
                       3.5.2 Standards & Compliances
                   3.6 Market Dynamics
                       3.6.1 Market Driver Analysis
                           3.6.1.1 Increasing demand for diagnostic tools in malaria-endemic countries
                           3.6.1.2 Development of technologically advanced and efficient diagnostics
                           3.6.1.3 Market players and private investors to curb the prevalence of malaria
                       3.6.2 Market Restraint Analysis
                           3.6.2.1 Increasing number of countries in the malaria elimination phase
                           3.6.2.2 Demand for low-cost malaria diagnostic tests
                       3.6.3 Industry Challenges
                   3.7 Malaria Diagnostics Market Analysis Tools
                       3.7.1 Industry Analysis - Porter’s
                           3.7.1.1 Supplier Power
                           3.7.1.2 Buyer Power
                           3.7.1.3 Substitution Threat
                           3.7.1.4 Threat from new entrant
                           3.7.1.5 Competitive rivalry
                       3.7.2 PESTEL Analysis
                           3.7.2.1 Political Landscape
                           3.7.2.2 Environmental Landscape
                           3.7.2.3 Social Landscape
                           3.7.2.4 Technology Landscape
                           3.7.2.5 Legal Landscape
                       3.7.3 Major Deals & Strategic Alliances Analysis
                       3.7.4 Market Entry Strategies
                       3.7.5 Case Studies
Chapter 4 Malaria Diagnostics Market: Competitive Analysis

Continued….

Healthcare Regulatory Affairs Outsourcing Market Segmentation by Type, Application, Regions, Key News and Top Companies Profiles 2027

The latest market report published by Reports and Data, titled ‘ Global Healthcare Regulatory Affairs Outsourcing Market ,’ offers a holisti...